Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor

被引:81
作者
Tanaka, N
Watanabe, J
Kitamura, T
Yamada, Y
Kanegasaki, S
Nakata, K
机构
[1] Univ Tokyo, Inst Med Sci, Lab Culture Collect, Minato Ku, Tokyo 1080071, Japan
[2] Kitasato Univ, Sch Med, Dept Med, Kanagawa 2288555, Japan
关键词
alveolar macrophage; peripheral blood; monocyte; bronchoalveolar lavage; interleukin-3; surfactant protein;
D O I
10.1016/S0014-5793(98)01668-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mice deficient in granulocyte-macrophage colony stimulating factor (GM-CSF) develop pulmonary alveolar proteinosis (PAP). We found that bronchoalveolar lavage fluid (BALF) from 11 patients with idiopathic pulmonary alveolar proteinosis (IPAP) suppressed the growth of peripheral blood monocytes and TF-1 cells, a cell line dependent on either GM-CSF or interleukin-3 (IL-3), The inhibitory effect of PAP-BALF occurred only when TF-1 cells were cultured with GM-CSF but not when cultured with IL-3, suggesting that PAP-BALF contains a factor that specifically interferes with GM-CSF function, I-125-GM-CSF binding to TF-1 cells was prevented in the presence of BALF from IPAP patients, Furthermore, crosslinking of I-125-GM-CSF to IPAP-BALF produced two major bands on SDS-PAGE; these bands were not observed in normal BALF. These data suggest that IPAP is caused by expression of binding factor(s) which inhibit GM-CSF function in the lung. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:246 / 250
页数:5
相关论文
共 29 条
[1]   Bronchoalveolar lavage fluid composition in alveolar proteinosis - Early changes after therapeutic lavage [J].
Alberti, A ;
Luisetti, M ;
Braschi, A ;
Rodi, G ;
Iotti, G ;
Sella, D ;
Poletti, V ;
Benori, V ;
Baritussio, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) :817-820
[2]  
[Anonymous], 1983, J IMMUNOL METH
[3]  
BACCHETTA R, 1990, J IMMUNOL, V144, P902
[4]   Surfactant protein A is degraded by alveolar macrophages [J].
Bates, SR ;
Fisher, AB .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1996, 271 (02) :L258-L266
[5]   IN-VITRO CHARACTERIZATION OF THE HUMAN RECOMBINANT SOLUBLE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR [J].
BROWN, CB ;
BEAUDRY, P ;
LAING, TD ;
SHOEMAKER, S ;
KAUSHANSKY, K .
BLOOD, 1995, 85 (06) :1488-1495
[6]  
CHIBA S, 1990, LEUKEMIA, V4, P29
[7]   UPDATE ON THE CLINICAL-DIAGNOSIS, MANAGEMENT, AND PATHOGENESIS OF PULMONARY ALVEOLAR PROTEINOSIS (PHOSPHOLIPIDOSIS) [J].
CLAYPOOL, WD ;
ROGERS, RM ;
MATUSCHAK, GM .
CHEST, 1984, 85 (04) :550-558
[8]   MECHANISM OF DYE RESPONSE AND INTERFERENCE IN THE BRADFORD PROTEIN ASSAY [J].
COMPTON, SJ ;
JONES, CG .
ANALYTICAL BIOCHEMISTRY, 1985, 151 (02) :369-374
[9]   A FUNCTIONAL ISOFORM OF THE HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR HAS AN UNUSUAL CYTOPLASMIC DOMAIN [J].
CROSIER, KE ;
WONG, GG ;
MATHEYPREVOT, B ;
NATHAN, DG ;
SIEFF, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) :7744-7748
[10]   Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression [J].
Dirksen, U ;
Nishinakamura, R ;
Groneck, P ;
Hattenhorst, U ;
Nogee, L ;
Murray, R ;
Burdach, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2211-2217